[Development of coronary collaterals following oral long-term therapy with nifedipine. Increased survival time following experimental coronary occlusion].
D000284:Administration, Oral; D000818:Animals; D003097:Collateral Circulation / Q000187:drug effects*; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000033:anatomy & histology / Q000502:physiology*; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D005260:Female; D008026:Ligation; D008297:Male; D009578:Nitrobenzenes / Q000008:administration & dosage / Q000494:pharmacology*; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents
Koronare Kollateralentwicklung nach oraler Langzeitbehandlung mit Nifedipine--erhöhte Uberlebensquote nach experimentellem Koronarverschluss